Editas Medicine Inc
NASDAQ:EDIT
Editas Medicine Inc
Tax Provision
Editas Medicine Inc
Tax Provision Peer Comparison
Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors
Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Editas Medicine Inc
NASDAQ:EDIT
|
Tax Provision
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Tax Provision
-$1.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-1%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Tax Provision
-$1.2B
|
CAGR 3-Years
8%
|
CAGR 5-Years
12%
|
CAGR 10-Years
-1%
|
|
Amgen Inc
NASDAQ:AMGN
|
Tax Provision
-$1.1B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-20%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Tax Provision
-$760.2m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-60%
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Tax Provision
-$245.7m
|
CAGR 3-Years
6%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
2%
|